Third generation oral contraceptives and the risk of venous thromboembolism: management of the uncertainty
Maling, T.J.
New Zealand Medical Journal 112(1094): 305-307
1999
ISSN/ISBN: 0028-8446 PMID: 10493438 Document Number: 503204
Document emailed within 1 workday
Related Documents
Boef, A.G.C.; Souverein, P.C.; Vandenbroucke, J.P.; van Hylckama Vlieg, A.; de Boer, A.; le Cessie, S.; Dekkers, O.M. 2016: Instrumental variable analysis as a complementary analysis in studies of adverse effects: venous thromboembolism and second-generation versus third-generation oral contraceptives Pharmacoepidemiology and Drug Safety 25(3): 317-324Spitzer, W.O.; Lewis, M.A.; Heinemann, L.A.; Thorogood, M.; MacRae, K.D. 1996: Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women Bmj 312(7023): 83-88
Jick, S.S.; Hernandez, R.K. 2011: Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data Bmj 342: D2151
Saguil, A. 2015: Risk of venous thromboembolism with use of combined oral contraceptives American Family Physician 91(5): 287-288
Brown, D.A.; Vartan, C.M. 2011: Risk of venous thromboembolism with drospirenone-containing oral contraceptives American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 68(11): 1003-1010
Suissa, S.; Blais, L.; Spitzer, W.O.; Cusson, J.; Lewis, M.; Heinemann, L. 1997: First-time use of newer oral contraceptives and the risk of venous thromboembolism Contraception 56(3): 141-146
Milsom, I.; Odlind, V.; von Schoultz, B.; Ostlund, I.; Persson, E. 2002: Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations Lakartidningen 99(1-2): 10-2 15
Milsom, I.; Odlind, V.; von Schoultz, B.; Ostlund, I.; Persson, E. 2002: Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations Lakartidningen 99(1-2): 10-2 15
Lidegaard, Øj.; Nielsen, L.H.; Skovlund, C.W.; Skjeldestad, F.E.; Løkkegaard, E. 2011: Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9 Bmj 343: D6423
Vinogradova, Y.; Coupland, C.; Hippisley-Cox, J. 2015: Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases Bmj 350: H2135
Plu-Bureau, Gève. 2015: Combined oral contraceptives and risk of venous thromboembolism: there is higher risk in new generations compared to second generations, but paradoxically not in norgestimate-containing-pills Evidence-Based Medicine 20(5): 189
Nightingale, A.L.; Lawrenson, R.A.; Simpson, E.L.; Williams, T.J.; MacRae, K.D.; Farmer, R.D. 2000: The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 5(4): 265-274
Sugimura, M.; Terao, T. 1999: Oral Contraceptives and Thrombosis. do Third-generation Oral Contraceptives Enhance Venous Thromboembolic Disease? Japanese Journal of Thrombosis and Hemostasis 10(2-3): 128-135
Machado, Rério.Bonassi.; Morimoto, M.; Santana, N.; Arruda, Lívia.Fernandes.; Bernardes, C.Rejane.; de Souza, I.Matias. 2015: Effect of information on the perception of users and prospective users of combined oral contraceptives regarding the risk of venous thromboembolism Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 31(1): 57-60
Jick, S.S.; Hagberg, K.W.; Hernandez, R.K.; Kaye, J.A. 2010: Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism Contraception 81(1): 16-21
Roke, C. 1997: Oral contraceptives and venous thromboembolism New Zealand Medical Journal 110(1036): 21
Paul, C. 1996: Oral contraceptives and venous thromboembolism New Zealand Medical Journal 109(1033): 413-415
Paul, C. 1996: Oral contraceptives and venous thromboembolism New Zealand Medical Journal 109(1033): 413-415
Skegg, D.C.G. 2002: Oral contraceptives, venous thromboembolism, and the courts Bmj 325(7363): 504-505
Greaves, M.; Preston, F.E. 2001: Rebuttal to: oral contraceptives and venous thromboembolism Thrombosis and Haemostasis 85(5): 932